School of Medicine - Clinical MedicineUrology




We provide advanced medical treatment for malignant tumors of the kidney, renal pelvis, ureter, bladder, and prostate. Brachytherapy of prostate cancer was done successfully at our department for the first time in Ishikawa prefecture, and we have treated more than 350 prostate cancer cases since then. In addition, we have performed 150 Robot-assisted radical prostatectomy (RALP) and 30 Robot-assisted partial nephrectomy (RAPN). In 1975, we performed the first living kidney transplantation in Ishikawa, and we have done 255 living and 65 cadaveric kidney transplantations. To treat urinary tract stones, we have implemented the latest diagnostic and treatment methods, including extracorporeal shock wave lithotripsy (ESWL), transurethral ureterolithotripsy (TUL), and percutaneous nephrolithotripsy (PNL). All kinds of urological problems such as benign prostatic hyperplasia (BPH) and urinary incontinence cases are diagnosed expediently and treated with surgery and/or medicine in our hospital.

Contact Information

TEL: 076-286-2211 内線:3314 / FAX: 076-286-5516 / Email:


Professor and Chair

  • MIYAZAWA Katsuhito


  • TANAKA Tatsuro

Senior Assistant Professor

  • MORITA Nobuyo

Assistant Professor

  • SUGA Koudai
  • NAKAZAWA Yusuke
  • INOUE Shinya
  • USHIMOTO Chiharuko
  • KUNII Kenshiro

Research Achievements

Research Activities

  • Nakazawa Y, Inoue S, Miyazawa K, et al. High-salt diet promotes crystal deposition via hypertension in Dahl salt-sensitive rat model. Int J Urol. 2019 26: 839-846.
  • Sakamoto S, Miyazawa K, Yasui T, et al. Chronological changes in the epidemiological characteristics of upper urinary tract urolithiasis in Japan. Int J Urol. 2018. 25: 373-378.
  • Sorokin I, Mamoulakis C, Miyazawa K, et al. Epidemiology of stone disease across the world. World J Urol. 2017. 35: 1301–1320.
  • K. Miyazawa, T. Tanaka, D. Nakai, N. Morita and K. Suzuki: Immunohistochemical expression of four different stem cell markers in prostate cancer: High expression of NANOG in conjunction with hypoxia-inducible factor-1α expression is involved in prostate epithelial malignancy. Oncol lett, 2014. 8: 985-992.
  • K.Miyazawa, M.Matoba, H.Minato, N.Morita, I.Chikazawa, K.Ota, K.Tokunaga, H.Tonami, T.Nojima, K.Suzuki: Seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds: analysis of its incidence and risk factors. Jpn. J. Radiol. 2014. 30:635-641.